Manifestaciones sistémicas y extrapulmonares en la COVID-19

  1. Balsa Vázquez, J. 1
  2. Alonso Menchén, D. 1
  3. Martín Llorens, M.M. 1
  4. Sanz Moreno, J. 1
  1. 1 Servicio de Medicina Interna. Hospital Universitario Príncipe de Asturias. Universidad de Alcalá. Alcalá de Henares. Madrid. España
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2022

Issue Title: Enfermedades infecciosas (VII)

Series: 13

Issue: 55

Pages: 3235-3245

Type: Article

DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Although fever and respiratory symptoms are the main clinical expression of COVID-19 disease, important extrapulmonary complications that affect the majority of the organs and systems may occur. Multisystemic involvement can mainly be attributed to the generalized location of ACE2 receptors throughout the body, which act as the main point of entry for the virus. Systemic manifestations may occasionally appear before the typical symptoms, although they generally occur later or are sequelae of the disease. Thromboembolic complications are concerning due to their frequency and severity; they are the result of a hypercoagulable state with multiple possible clinical manifestations. Cardiac, neurological, gastrointestinal, renal, endocrine-metabolic, skin, and ocular complications may occur. The manifestations and specific therapeutic aspects of COVID-19 disease in pregnant women as well as implications of the disease on children are discussed. The corresponding tests must be performed in all patients with a clinical suspicion of COVID-19 in order to confirm the diagnosis of the infection. The specific diagnostic tests that are indicative of involvement of different organs are guided based on clinical suspicion. These tests are conducted on an individual basis taking into account the isolation measures required and the severity of each case. Likewise, the corresponding treatment is administered according to criteria that generally similar to those for the general population.

Bibliographic References

  • Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-32.
  • Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID-19 and venous thromboembolism: A meta-analysis of literature studies. Semin Thromb Hemost. 2020;46:763-71.
  • Suh YJ, Hong H, Ohana M, Bompard F, Revel MP, Valle C. Pulmonary embolism and deep vein thrombosis in COVID-19: A systematic review and meta-analysis. Radiology. 2021;298(2):E70-E80.
  • Agbuduwe C, Basu S. Haematological manifestations of COVID-19: From cytopenia to coagulopathy. Eur J Haematol. 2020;105(5):540-6.
  • Franco López A, Escribano Poveda J, Vicente Gilabert N. Tromboembolismo pulmonar en los pacientes con COVID-19. Angiografía computarizada: resultados preliminares. JONNPR. 2020:5(6):616-30.
  • Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 2021;5:872.
  • Elkind M, Cucchiara B, Koralnik D, Rabinstein A, Kasner S, Goddeau R. COVID-19: Neurologic complications and management of neurologic conditions. Uptodate 2021
  • Case BC, Yerasi C, Forrestal BJ, Shea C, Rappaport H, Medranda GA. Clinical impact and predictors of troponin elevation in patients with COVID-19. Cardiovasc. Revasc Med. 2021. 33:41-4.
  • Rosovsky RP, Grodzin C, Channick R, Davis GA, Giri JS, Horowitz J. Diagnosis and treatment of pulmonary embolism during the coronavirus disease 2019 pandemic: A position paper from the national PERT Consortium. Chest. 2020;158(6):2590-601.
  • Cuker A, Peyvandi F, Leung L, Tirnauer J. COVID-19: Hypercoagulability [Internet]. Uptodate 2021
  • Piera Carbonell A, Frías Vargas M, García Vallejo O, García Lerín A, Cabrera Ferriols MA, Peiró Morant J. COVID-19 y trombopro- filaxis: recomendaciones para nuestra práctica clínica en Atención Primaria. Semergen. 2020;46(7):479-86.
  • Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8.
  • Linschoten M, Peters S, van Smeden M, Jewbali LS, Schaap J, Siebelink HM. Cardiac complications in patients hospitalised with COVID-19. Eur Heart J Acute Cardiovasc Care. 2020;9(8):817-23.
  • Cordero Q, Escuadra M. Miocarditis, evaluación por imagen. Cardioimagen. 2018.
  • Caforio A, Mancini D, Yeon S. COVID-19: Cardiac manifestations in adults. Uptodate 2021
  • Singh A, Zaheer S, Kumar N, Singla T, Ranga S. Covid19, beyond just the lungs: A review of multisystemic involvement by Covid19. Pathol Res Pract. 2021;224:153384.
  • Caforio A, Mancini D, Yeon S. COVID-19: Evaluation and management of cardiac disease in adults. Uptodate 2021
  • De Felice FG, Tovar Moll F, Moll J, Muñoz DP, Ferreira ST. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends Neurosci. 2020;43(6):355-7.
  • Chou SH, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V. Global incidence of neurological manifestations among patients hospitalized with COVID-19-a report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open. 2021;4:e2112131.
  • Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020;7(11):2221-30.
  • Mao L, Jin H, Wang M, Hu Y, Chen S, He Q. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90.
  • Lechien JR, Chiesa Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277:2251.
  • Renaud M, Thibault C, Le Normand F, Mcdonald EG, Gallix B, Debry C. Clinical outcomes for patients with anosmia 1 year after COVID-19 diagnosis. JAMA Netw Open. 2021;4(6):e2115352.
  • Zuberbühler P, Conti ME, León Cejas L, Maximiliano González F, Bonardo P, Miquelini A. Guillain-Barre syndrome associated to COVID-19 infection: a review of published case reports. Rev Neurol. 2021;72(6):203-12.
  • Hunt RH, East JE, Lanas A, Malfertheiner P, Satsangi J, Scarpignato C. COVID-19 and gastrointestinal disease: Implications for the gastroenterologist. Dig Dis. 2021;39(2):119-39.
  • Cheung KS, Hung IF, Chan PP, Lung KC, Tso E, Liu R. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. Gastroenterology. 2020;159(1):81-95.
  • Tian D, Ye Q. Hepatic complications of COVID-19 and its treatment. J Med Virol. 2020;92(10):1818-24.
  • Kaafarani HMA, El Moheb M, Hwabejire JO, Naar L, Christensen MA, Breen K. Gastrointestinal complications in critically Ill patients with COVID-19. Ann Surg. 2020;272:e61.
  • Eldaly AS, Fath AR, Mashaly SM, Elhadi M. Acute pancreatitis associated with severe acute respiratory syndrome coronavirus-2 infection: a case report and review of the literature. J Med Case Rep. 2021;15(1):461.
  • Kaafarani H, Weiser M, Chen Wenliang. COVID-19: Gastrointestinal symptoms and complications. Uptodate 2021
  • Gartland RM, Velmahos GC. Bowel necrosis in the setting of COVID-19. J Gastrointest Surg. 2020;24:2888
  • Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32(1): 151-60.
  • Vargas JG, Avila N, Hurtado D, Cárdenas Roldán J, Peña D, Ortiz G. Lesión renal aguda en COVID-19: puesta al día y revisión de la literatura. Acta Colomb Cuid Intensivo. 2020.
  • Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43:1027-31.
  • Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020;22(10): 1935-41.
  • Genovese G, Moltrasio C, Berti E, Marzano A. Skin manifestations associated with COVID-19: Current knowledge and future perspectives. Dermatology 2021;237:1-12.
  • Pérez Bartolomé F, Sánchez Quirós J. Ocular manifestations of SARS-CoV-2: Literature review. Arch Soc Esp Oftalmol (Engl Ed). 2021;96(1):32-40
  • Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601-15.
  • Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1641.
  • Berghella V, Hughes B, Lockwood C, Barss V. COVID-19: Pregnancy issues and antenatal care. Uptodate 2021
  • Deville JG, Song E, Ouellette CP. COVID-19: Clinical manifestations and diagnosis in children. Uptodate 2021
  • Son MBF, Friedman K. COVID-19: Multisystem inflammatory syndrome in children (MIS-C) management and outcome. Uptodate 2021
Data source: Dialnet